clinical Information
-
DRAMP ID
- DRAMP18083
-
Sequence
- (CKPV)2
-
Sequence Name
- CZEN-002
-
Description
- synthetic 8-mer derived from α-melanocyte-stimulating hormone
-
Activity
- anti-candidal
-
Medical use
- Vulvovaginal candidiasis
-
Stage of Development
- Phase IIb
-
Comments
- Positive efficacy results announced. Phase IIb trial is a dose-ranging study
-
Company
- Zengen(Woodland Hills, CA, USA)
-
Target Organism
-
- No MICs found on DRAMP database
-
Reference
-
- Antimicrobial peptides: therapeutic potential. Expert Opin. Pharmacother. (2006).